glp 1 oral meds List of approved and pending GLP-1 medications GLP-1 Agonists: A Comprehensive Overview
Description
Muscle cramps, fatigue, heart palpitations, and dizziness may signal electrolyte imbalance rather than simple calorie restriction
The evidence is presented in the guidance document
Headaches may recur briefly after dose increases but typically resolve with continued use and supportive measures like adequate hydration
Cutaneous adverse events (CAEs) to GLP-1 agonists were retrospectively reviewed using the FDA Adverse Event Reporting System (FAERS)
